Insider Selling: Intuitive Surgical (NASDAQ:ISRG) EVP Sells 28 Shares of Stock

July 30, 2026 by InsiderTrades.com

Key Points

Intuitive Surgical EVP Mark Brosius sold 28 shares at an average price of $360.21, totaling $10,085.88. The transaction was conducted under a pre-arranged Rule 10b5-1 plan and reduced his holdings by about 2%.
Despite beating quarterly earnings and revenue estimates—reporting $2.80 EPS and $2.89 billion in revenue—Intuitive Surgical shares have faced pressure amid concerns about softer U.S. procedure growth and deferred care.
Analysts remain broadly positive, with the stock carrying a “Moderate Buy” consensus rating and an average price target of $517.21, well above its recent price near $353.

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Mark Brosius sold 28 shares of the firm's stock in a transaction on Wednesday, July 29th. The stock was sold at an average price of $360.21, for a total value of $10,085.88. Following the transaction, the executive vice president directly owned 1,322 shares of the company's stock, valued at $476,197.62. The trade was a 2.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Why Intuitive Surgical’s Strong Quarter Still Spooked Investors

Mark Brosius also recently made the following trade(s):

On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $344.00, for a total transaction of $9,632.00.
On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $414.13, for a total transaction of $10,353.25.
On Wednesday, June 10th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $424.14, for a total transaction of $9,755.22.
On Monday, June 8th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $420.12, for a total transaction of $9,662.76.
On Friday, May 22nd, Mark Brosius sold 18 shares of Intuitive Surgical stock. The stock was sold at an average price of $439.80, for a total transaction of $7,916.40.
On Wednesday, May 20th, Mark Brosius sold 18 shares of Intuitive Surgical stock. The shares were sold at an average price of $440.38, for a total value of $7,926.84.
On Monday, May 18th, Mark Brosius sold 18 shares of Intuitive Surgical stock. The stock was sold at an average price of $422.47, for a total value of $7,604.46.

Intuitive Surgical Stock Down 2.4%

ISRG stock opened at $353.10 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The stock's fifty day simple moving average is $401.70 and its 200-day simple moving average is $454.32. The stock has a market capitalization of $124.74 billion, a price-to-earnings ratio of 40.45, a price-to-earnings-growth ratio of 2.62 and a beta of 1.46.

Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business's revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.81 earnings per share. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. Prosperity Consulting Group LLC lifted its stake in shares of Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider's stock valued at $1,804,000 after purchasing an additional 19 shares in the last quarter. Sunburst Financial Group LLC grew its holdings in shares of Intuitive Surgical by 4.3% during the 4th quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider's stock worth $275,000 after purchasing an additional 20 shares during the period. WoodTrust Financial Corp increased its position in Intuitive Surgical by 0.5% during the 4th quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider's stock worth $2,367,000 after purchasing an additional 20 shares in the last quarter. North Star Investment Management Corp. increased its position in Intuitive Surgical by 8.5% during the 4th quarter. North Star Investment Management Corp. now owns 269 shares of the medical equipment provider's stock worth $152,000 after purchasing an additional 21 shares in the last quarter. Finally, Cornerstone Planning Group LLC raised its holdings in Intuitive Surgical by 11.5% in the fourth quarter. Cornerstone Planning Group LLC now owns 203 shares of the medical equipment provider's stock valued at $106,000 after buying an additional 21 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical News Roundup

5 Stocks Racing Ahead as AI Supercharges Robotics

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Analysts remain broadly optimistic about Intuitive Surgical’s long-term prospects. Reports cite an average Wall Street price target of about $484 and one target of $685, implying significant upside from recent levels. The company’s installed da Vinci system base, recurring instrument and accessory revenue, and durable demand support the bullish view. Why Wall Street Thinks Intuitive Surgical Could Rise Intuitive Surgical Price Target
Positive Sentiment: Management’s second-quarter commentary indicated durable platform demand and higher margin guidance, suggesting that procedure growth and profitability remain structurally attractive despite near-term volatility. ISRG Q2 Earnings Call Signals Durable Demand
Positive Sentiment: A new awareness campaign with Deion “Coach Prime” Sanders could increase patient understanding of robotic-assisted surgery and support future procedure demand. Why Intuitive Surgical Shares Rose
Neutral Sentiment: Intuitive Surgical overhauled its bylaws governing director nominations, shareholder proposals, and special meetings. The changes may improve governance clarity but also alter shareholder participation rights; analysts view the revisions alongside the stock’s weakness as part of a potential undervaluation case. Intuitive Surgical Undervaluation and Bylaw Changes
Neutral Sentiment: Executive vice president Mark Brosius reported two small stock sales under a pre-arranged Rule 10b5-1 plan. Because the transactions represented roughly 2% of his holdings, they are unlikely to materially change the investment case. SEC Insider Trading Filing
Negative Sentiment: The post-earnings selloff reflects investor caution despite quarterly results that exceeded expectations. Management warned of softer U.S. procedure growth and deferred care, raising concerns about near-term utilization and valuation. Intuitive Surgical Post-Earnings Selloff ISRG Q2 Earnings Call Signals

Wall Street Analysts Forecast Growth

ISRG has been the subject of several recent analyst reports. The Goldman Sachs Group set a $558.00 price target on Intuitive Surgical in a report on Wednesday, May 27th. BTIG Research decreased their target price on shares of Intuitive Surgical from $512.00 to $469.00 and set a "buy" rating on the stock in a research report on Friday, July 17th. Jefferies Financial Group decreased their target price on shares of Intuitive Surgical from $560.00 to $515.00 and set a "hold" rating on the stock in a research report on Wednesday, April 22nd. Evercore set a $430.00 target price on shares of Intuitive Surgical in a report on Monday, July 6th. Finally, Sanford C. Bernstein dropped their price target on shares of Intuitive Surgical from $750.00 to $685.00 and set an "outperform" rating for the company in a research report on Friday, July 17th. Twenty-one analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $517.21.

View Our Latest Stock Report on Intuitive Surgical

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.